Company Profile

EastPharma Ltd. is the indirect holding company of Deva Holding A.S. (Deva), a pharmaceutical company. The Company operates in the pharmaceutical industry. The Company has three segments: production and sale of human pharmaceuticals (Human Pharma), Veterinary Products and Other. The Human Pharma segment comprises the manufacturing and sale of antibiotic active ingredients and empty ampoules. The Veterinary products segment operates in the sector of veterinary drugs and agrochemicals. Its Other segment includes cologne production and sale. The Company offers medicines indicated for alimentary, metabolism and cardiovascular system and infections. It also conducts, at its microbiology laboratories, tests and research on the adaptation of raw materials, selection of micro-organisms, formulation of culture mediums, and executes various test and research fermentations on pilot fermentators. It has over 150 pharmaceutical molecules in approximately 270 pharmaceutical forms.

Employees

1,765

Sector

Pharmaceuticals

More about the company

23-03-23	Eastpharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-03-05	Eastpharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
20-03-05	Eastpharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	CI
19-03-08	Eastpharma Ltd Reports Earnings Results for the Full Year Ended December 31, 2018	CI
18-09-10	Investimentos Corp. acquired 8.2% stake of EastPharma Ltd. from D.E. Shaw Laminar Portfolios, LLC.	CI
18-08-13	EastPharma Ltd. Reports Consolidated Earnings Results for the Six Months Ended June 30, 2018	CI
18-03-09	Eastpharma Announces Audited Earnings Results for the Year Ended December 31, 2017	CI
17-08-10	EastPharma Ltd Reports Earnings Results for the Six Months Ended June 30, 2017	CI
17-05-03	EastPharma Ltd. Reports Revenue Results for the First Quarter Ended March 31, 2017	CI
17-03-10	EastPharma Ltd. Reports Audited Earnings Results for the Year Ended December 31, 2016	CI
16-11-03	EastPharma Ltd. Reports Consolidated Sales Results for the Nine Months Ended September 30, 2016	CI
16-08-10	Eastpharma Ltd. Reports Consolidated Earnings Results for the Six Months Ended June 30, 2016	CI
16-05-10	EastPharma Ltd Announces Sales Results for the First Quarter Ended 31 March 2016	CI

Manager	Title	Age	Since
Philipp Haas CEO	Chief Executive Officer	-	2007-12-31
Mesut Çetin DFI	Director of Finance/CFO	47	-

Director	Title	Age	Since
Philipp Haas CHM	Chairman	-	2007-12-31
Mesut Çetin BRD	Director/Board Member	47	2013-02-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EASTPHARMA LTD.	-7.69%	-14.29%	-	-	40.59M
ELI LILLY AND COMPANY	+1.18%	-3.43%	+36.07%	+115.04%	1,019B
JOHNSON & JOHNSON	-0.86%	-5.60%	+35.72%	+64.63%	617B
ABBVIE INC.	-0.65%	-0.58%	+12.36%	+77.95%	464B
MERCK & CO., INC.	-2.26%	-3.01%	+61.79%	+41.24%	356B
ROCHE HOLDING AG	+0.61%	-2.08%	+20.67%	+41.06%	333B
NOVARTIS AG	+0.26%	-3.36%	+10.89%	+34.50%	267B
ASTRAZENECA PLC	-0.44%	-4.92%	-6.66%	+8.95%	244B
AMGEN INC.	-0.56%	-2.79%	+35.30%	+51.84%	218B
GILEAD SCIENCES, INC.	-0.56%	-4.10%	+28.44%	+93.66%	179B
Average	-1.14%	-3.54%	+26.06%	+58.76%	410.8B
Weighted average by Cap.	-0.19%	-3.54%	+29.08%	+70.63%

EastPharma Ltd. Stock

Stocks

EAST

US27778Q2049

Pharmaceuticals

Latest news: EastPharma Ltd.

Quotes and Performance

Managers and Directors: EastPharma Ltd.

Generic Pharmaceuticals

Company Profile